1-20 of 22
Authors: Patrick N. Harter
Save search
Sort by
Journal Article
ACCEPTED MANUSCRIPT

Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes Get access

PDF
Philipp Sievers and others
Neuro-Oncology, noaf105, https://doi.org/10.1093/neuonc/noaf105
Published: 18 April 2025
Journal Article

Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments Get access

PDF
Katharina J Müller and others
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 77–88, https://doi.org/10.1093/neuonc/noae208
Published: 19 November 2024
Journal Article

EXTH-13. COMBINED ANTI-ANGIOGENIC TREATMENT TO INCREASE INTRATUMORAL PERSISTENCE OF CAR T-CELLS IN LUNG CANCER BRAIN METASTASES

PDF
Jens Blobner and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii239, https://doi.org/10.1093/neuonc/noae165.0944
Published: 11 November 2024
Journal Article

PATH-12. CLINICAL AND NEUROPATHOLOGICAL MARKERS FOR DISTINGUISHING BETWEEN IDH-MUTANT ASTROCYTOMAS OF WHO GRADE 2 AND 3

PDF
Jens Blobner and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii180, https://doi.org/10.1093/neuonc/noae165.0711
Published: 11 November 2024
Journal Article

Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation

PDF
Patrick N Harter and others
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae138, https://doi.org/10.1093/noajnl/vdae138
Published: 02 August 2024
Journal Article

EPEN-14. MOLECULAR MARKERS AND PREDICTORS OF OUTCOME FOR PAEDIATRIC INTRACRANIAL EPENDYMOMA IN THE PROSPECTIVE, MULTICENTRE E-HIT2000 TRIAL AND SUBSEQUENT HIT-REGISTRIES: A POOLED ANALYSIS OF 244 PATIENTS

PDF
David R Ghasemi and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.216
Published: 18 June 2024
Journal Article

Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasis

PDF
Jenny Roesler and others
Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 2084–2099, https://doi.org/10.1093/neuonc/noae094
Published: 04 June 2024
Includes: Multimedia
Journal Article

Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastoma

PDF
Iris Divé and others
Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdad131, https://doi.org/10.1093/noajnl/vdad131
Published: 17 October 2023
Journal Article

Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma

PDF
Alicia Eckhardt and others
Neuro-Oncology, Volume 26, Issue 3, March 2024, Pages 503–513, https://doi.org/10.1093/neuonc/noad197
Published: 11 October 2023
Journal Article

Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma

PDF
Jens Blobner and others
Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdad060, https://doi.org/10.1093/noajnl/vdad060
Published: 12 May 2023
Journal Article

Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma

PDF
Michael C Burger and others
Neuro-Oncology, Volume 25, Issue 11, November 2023, Pages 2058–2071, https://doi.org/10.1093/neuonc/noad087
Published: 06 May 2023
Journal Article

DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients

PDF
Richard Drexler and others
Neuro-Oncology, Volume 25, Issue 2, February 2023, Pages 315–325, https://doi.org/10.1093/neuonc/noac177
Published: 22 July 2022
Journal Article

HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma

PDF
Marius Felix and others
Neuro-Oncology, Volume 24, Issue 12, December 2022, Pages 2121–2132, https://doi.org/10.1093/neuonc/noac111
Published: 03 May 2022
Journal Article

BSCI-11. Targeting PI3K/Akt/mTOR pathway to prevent melanoma brain metastasis

PDF
Cedric Tehranian and others
Neuro-Oncology Advances, Volume 3, Issue Supplement_3, August 2021, Page iii3, https://doi.org/10.1093/noajnl/vdab071.010
Published: 09 August 2021
Journal Article

The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis

PDF
Cedric Tehranian and others
Neuro-Oncology, Volume 24, Issue 2, February 2022, Pages 213–225, https://doi.org/10.1093/neuonc/noab159
Published: 03 July 2021
Journal Article

A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR

PDF
Philipp Sievers and others
Neuro-Oncology, Volume 23, Issue 1, January 2021, Pages 34–43, https://doi.org/10.1093/neuonc/noaa251
Published: 01 November 2020
Journal Article

Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma

PDF
Tanja Eisemann and others
Neuro-Oncology, Volume 21, Issue 3, March 2019, Pages 326–336, https://doi.org/10.1093/neuonc/noy184
Published: 10 November 2018
Journal Article

EGFR heterogeneity and implications for therapeutic intervention in glioblastoma

PDF
Eskil Eskilsson and others
Neuro-Oncology, Volume 20, Issue 6, June 2018, Pages 743–752, https://doi.org/10.1093/neuonc/nox191
Published: 10 October 2017
Journal Article

The angiogenic switch leads to a metabolic shift in human glioblastoma

PDF
Krishna M. Talasila and others
Neuro-Oncology, Volume 19, Issue 3, 1 March 2017, Pages 383–393, https://doi.org/10.1093/neuonc/now175
Published: 03 September 2016
Journal Article

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation

PDF
Eskil Eskilsson and others
Neuro-Oncology, Volume 18, Issue 12, 1 December 2016, Pages 1644–1655, https://doi.org/10.1093/neuonc/now113
Published: 10 June 2016